Does ELETRIPTAN Cause Reversible cerebral vasoconstriction syndrome? 13 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Reversible cerebral vasoconstriction syndrome have been filed in association with ELETRIPTAN. This represents 4.0% of all adverse event reports for ELETRIPTAN.
13
Reports of Reversible cerebral vasoconstriction syndrome with ELETRIPTAN
4.0%
of all ELETRIPTAN reports
0
Deaths
7
Hospitalizations
How Dangerous Is Reversible cerebral vasoconstriction syndrome From ELETRIPTAN?
Of the 13 reports, 7 (53.8%) required hospitalization.
Is Reversible cerebral vasoconstriction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELETRIPTAN. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does ELETRIPTAN Cause?
Drug ineffective (91)
Therapeutic product effect incomplete (27)
Foetal exposure during pregnancy (25)
Migraine (24)
Headache (23)
Off label use (23)
Vomiting (23)
Product use in unapproved indication (22)
Nausea (21)
Treatment failure (17)
What Other Drugs Cause Reversible cerebral vasoconstriction syndrome?
ESCITALOPRAM OXALATE (165)
FLUOXETINE (154)
TACROLIMUS (127)
METHYLPREDNISOLONE (119)
SUMATRIPTAN (105)
VENLAFAXINE (105)
DULOXETINE (102)
SERTRALINE (102)
MYCOPHENOLATE MOFETIL (68)
CITALOPRAM HYDROBROMIDE (64)
Which ELETRIPTAN Alternatives Have Lower Reversible cerebral vasoconstriction syndrome Risk?
ELETRIPTAN vs ELETRIPTAN HYDROBROMIDE
ELETRIPTAN vs ELEXACAFTOR\IVACAFTOR\TEZACAFTOR
ELETRIPTAN vs ELIGLUSTAT
ELETRIPTAN vs ELIQUIS
ELETRIPTAN vs ELOSULFASE ALFA